Drugs / Titanium Dioxide Nanoparticles
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06904118 | Jun → Dec 2023 | dentin sensitivity | Pakistan Institute of Medical Sciences | Completed | No outcome recorded |
| — | NCT03666195 | Oct → Dec 2018 | candidiasis, denture stomatitis | Cairo University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06025084 Comparator | Dec 2022 → Mar 2023 | dentin sensitivity | Egymedicalpedia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Titanium Dioxide Nanoparticles | “In group A; Nano-fortified Novel TiHP gel (Titanium Dioxide nanoparticles and 35 % Hydrogen Peroxide ) will be used for the participants of Group-A and Conventional bleaching...” NCT06904118 ↗ |
| Known as | Egg Shell nanoparticles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06025084 ↗ |
| Modality | Other / unclassified | “nanoparticulate metals such as TiO2, SiO2, ZnO, Ag, CuO” NCT03666195 ↗ |